Impatiens-type Penetrate-Bone Herb

Chinese
凤仙透骨草
Pinyin
Feng Xian Tou Gu Cao
Latin
Herba Speranskiae Tuberculatae

TCM Properties

Taste
pungent
Temperature
warm
Channels
Liver, Kidney

Traditional Use

Primary Actions

  • Dispels Wind-Damp and relieves Bi syndrome — rheumatic joint and muscle pain, especially cold-damp type with stiffness and heaviness
  • Warms channels and disperses Cold — cold-obstructed pain in the joints, lumbar region, and extremities
  • Relaxes sinews and relieves spasm — muscle cramps and sinew contracture from Cold-Damp obstruction
  • External use for joint pain and injuries — decoction wash or poultice for arthritic swelling and traumatic injuries

Secondary Actions

  • Promotes menstruation — mild Blood-moving action; used in north China folk medicine for amenorrhea with Cold pattern
  • Folk antimicrobial — topical decoction wash for fungal nail infections and tinea pedis in traditional east China practice

Classic Formulas

  • Tou Gu Cao Wan or decoction formulations — combined with Wei Ling Xian (威灵仙), Du Huo (独活), Fang Feng (防风), and Gui Zhi (桂枝) for Wind-Cold-Damp Bi syndrome with cold-predominant joint pain; used as the Tou Gu Cao drug in regional formulas where the Impatiens-derived variant is the available source

Classical References

  • SPECIES DISAMBIGUATION: The pinyin 'Feng Xian Tou Gu Cao' (凤仙透骨草) indicates the Impatiens-derived variant of Tou Gu Cao — 'Feng Xian' (凤仙) is Impatiens balsamina L. (garden balsam/touch-me-not; Balsaminaceae), used as a regional source of Tou Gu Cao in northern and eastern China; the XLSX source assigns the official Latin Herba Speranskiae Tuberculatae (which strictly refers to Speranskia tuberculata) to both this herb (#84) and the primary Tou Gu Cao drug (#85) — the two plants share the TCM indication for Wind-Damp Bi syndrome but differ in botanical source; Impatiens balsamina is also the source of Ji Xing Zi (急性子, seeds) and Feng Xian Hua (凤仙花, flowers), two separate TCM drugs
  • Shan Dong Zhong Cao Yao Shou Ce (山东中草药手册): documents Feng Xian Tou Gu Cao specifically as the Impatiens balsamina-derived penetrate-bone herb used in Shandong folk medicine for rheumatic pain, arthritic joints, and menstrual irregularities

Modern Research

Active Compounds

  • 2-Methoxy-1,4-naphthoquinone (lawsone precursor; from Impatiens species; anti-inflammatory, antifungal)
  • Kaempferol and quercetin glycosides (flavonoids; anti-inflammatory, antioxidant)
  • Balsaminol A and B (sesquiterpene alcohols; anti-inflammatory)
  • Phenolic acids: p-coumaric acid, ferulic acid (antioxidant, anti-inflammatory)
  • Sterols: β-sitosterol, stigmasterol

Studied Effects

  • Anti-inflammatory and analgesic: flavonoid and naphthoquinone fractions from Impatiens balsamina inhibit COX-2 and prostaglandin E2 synthesis in inflammatory cell models; hot-plate and acetic-acid writhing tests in rodents confirm central and peripheral analgesic activity — validates the Wind-Damp pain-relieving indication
  • Antifungal: 2-methoxy-1,4-naphthoquinone from I. balsamina shows strong antifungal activity against Candida albicans, Trichophyton rubrum, and Microsporum canis in MIC assays — provides mechanistic basis for the traditional folk use as a topical soak for fungal nail infections and tinea
  • Anti-arthritic: aqueous and ethanol extracts of I. balsamina reduce paw swelling and pro-inflammatory cytokine levels in adjuvant-induced arthritis models; mechanism involves NF-κB pathway inhibition — supports the Bi-syndrome application for rheumatic joint disease

Safety & Interactions

Contraindications

  • Heat-type Bi syndrome (hot, red, swollen joints with fever) — warm-pungent nature contraindicated
  • Pregnancy: Blood-moving action; traditional caution; high doses avoided

Cautions

  • Standard dose: 9–15 g dried herb in decoction; commonly used as a decoction wash (30–60 g) for external joint and skin applications
  • Topical use: concentrated decoction may cause mild skin irritation in sensitive individuals; patch test before extended topical use
  • No significant systemic drug interactions identified at standard therapeutic doses

Conditions